Koyfin Home > Directory > Health Care > Revance Therapeutics > Diluted EPS Excl. Extra Items

Revance Therapeutics Diluted EPS Excl. Extra Items Chart (RVNC)

Revance Therapeutics annual/quarterly Diluted EPS Excl. Extra Items from 2012 to 2020. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Revance Therapeutics Diluted EPS Excl. Extra Items for the quarter ending June 06, 2020 was $-1m a 14.39% decrease of 0m year over year
  • Revance Therapeutics Diluted EPS Excl. Extra Items for the last 12 months ending June 06, 2020 was $-4m a 11.43% decrease of 0m year over year
  • Revance Therapeutics Annual Diluted EPS Excl. Extra Items for 2019 was $-4m a -7.44% increase of 0m from 2018
  • Revance Therapeutics Annual Diluted EPS Excl. Extra Items for 2018 was $-4m a -1.64% increase of 0m from 2017
  • Revance Therapeutics Annual Diluted EPS Excl. Extra Items for 2017 was $-4m a 20.74% decrease of -1m from 2016
Other Per Share Metrics:
  • Revance Therapeutics Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 12.98% decrease of 0m year over year
View Chart On Koyfin

Quarterly RVNC Diluted EPS Excl. Extra Items Data

06/2020$-1m
03/2020$-1m
12/2019$-1m
09/2019$-1m
06/2019$-1m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$-1m

Annual RVNC Diluted EPS Excl. Extra Items Data

2019$-4m
2018$-4m
2017$-4m
2016$-3m
2015$-3m
2014$-3m
2013$1m
2012$-290m
2011$-226m